{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:33:36Z","timestamp":1771666416276,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.autrev.2008.12.001","type":"journal-article","created":{"date-parts":[[2008,12,26]],"date-time":"2008-12-26T09:42:13Z","timestamp":1230284533000},"page":"373-378","source":"Crossref","is-referenced-by-count":21,"title":["PM1-Alpha ELISA: The assay of choice for the detection of anti-PM\/Scl autoantibodies?"],"prefix":"10.1016","volume":"8","author":[{"given":"Michael","family":"Mahler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marvin J.","family":"Fritzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.autrev.2008.12.001_bib1","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.autrev.2007.01.013","article-title":"Novel aspects of autoantibodies to the PM\/Scl complex: clinical, genetic and diagnostic insights","volume":"6","author":"Mahler","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2008.12.001_bib2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1172\/JCI108616","article-title":"Antinuclear antibody with distinct specificity for polymyositis","volume":"59","author":"Wolfe","year":"1977","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.autrev.2008.12.001_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF00915286","article-title":"Antibodies to a nuclear\/nucleolar antigen in patients with polymyositis overlap syndromes","volume":"4","author":"Reichlin","year":"1984","journal-title":"J Clin Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2008.12.001_bib4","first-page":"658","article-title":"Clinical relevance of PM-1 antibody and physiochemical characterization of PM-1 antigen","volume":"11","author":"Treadwell","year":"1984","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2008.12.001_bib5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.173.4.941","article-title":"Molecular characterization of an autoantigen of PM-Scl in the polymyositis\/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex","volume":"173","author":"Alderuccio","year":"1991","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.autrev.2008.12.001_bib6","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1084\/jem.176.4.973","article-title":"Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndrome-related nucleolar 100-kD protein","volume":"176","author":"Bluthner","year":"1992","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.autrev.2008.12.001_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1172\/JCI115895","article-title":"Cloning of a complementary DNA coding for the 100-kD antigenic protein of the PM-Scl autoantigen","volume":"90","author":"Ge","year":"1992","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.autrev.2008.12.001_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2249.1990.tb05291.x","article-title":"Identification of protein components reactive with anti-PM\/Scl autoantibodies","volume":"81","author":"Gelpi","year":"1990","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2008.12.001_bib9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/art.1780280221","article-title":"Nucleolar localization of the PM-Scl antigen","volume":"28","author":"Targoff","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2008.12.001_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0074-7696(06)51005-8","article-title":"Cell and molecular biology of the exosome: how to make or break an RNA","volume":"251","author":"Schilders","year":"2006","journal-title":"Int Rev Cytol"},{"issue":"2","key":"10.1016\/j.autrev.2008.12.001_bib11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/ar389","article-title":"Autoantibodies directed to novel components of the PM\/Scl complex, the human exosome","volume":"4","author":"Brouwer","year":"2002","journal-title":"Arthritis Res"},{"issue":"5","key":"10.1016\/j.autrev.2008.12.001_bib12","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/art.22237","article-title":"Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy","volume":"55","author":"Selva-O'Callaghan","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2008.12.001_bib13","first-page":"129","article-title":"Anti-pm\/scl antibodies in connective tissue disease: clinical and biological assessment of 14 patients","volume":"24","author":"Vandergheynst","year":"2006","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2008.12.001_bib14","first-page":"2169","article-title":"Patients with antibodies to both PmScl and dsDNA","volume":"31","author":"Warner","year":"2004","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2008.12.001_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/03009740500339961","article-title":"Dysphagia associated with anti-PM-Scl antibodies in systemic lupus erythematosus","volume":"35","author":"Borrows","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2008.12.001_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1196\/annals.1398.037","article-title":"Serological and clinical characterization of anti-dsDNA and anti-PM\/Scl double-positive patients","volume":"1109","author":"Mahler","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.autrev.2008.12.001_bib17","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/rheumatology\/39.8.927","article-title":"Acquired haemophilia and PM-Scl antibodies","volume":"39","author":"Beyne-Rauzy","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.autrev.2008.12.001_bib18","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R","article-title":"Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies","volume":"40","author":"Hausmanowa-Petrusewicz","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2008.12.001_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2008.12.001_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00005792-199211000-00001","article-title":"The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl","volume":"71","author":"Marguerie","year":"1992","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.autrev.2008.12.001_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/ar628","article-title":"The clinical relevance of autoantibodies in scleroderma","volume":"5","author":"Ho","year":"2003","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.autrev.2008.12.001_bib22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1468-3083.2004.00869.x","article-title":"Scleromyositis (scleroderma\/polimyositis overlap) is an entity","volume":"18","author":"Jablonska","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.autrev.2008.12.001_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.1780370111","article-title":"Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis","volume":"37","author":"Kuwana","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2008.12.001_bib24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/art.1780330508","article-title":"Immunogenetic associations of scleroderma-related antinuclear antibodies","volume":"33","author":"Genth","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"26","key":"10.1016\/j.autrev.2008.12.001_bib25","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.2174\/092986707782360150","article-title":"Synthetic peptides: the future of patient management in systemic rheumatic diseases?","volume":"14","author":"Kessenbrock","year":"2007","journal-title":"Curr Med Chem"},{"issue":"22","key":"10.1016\/j.autrev.2008.12.001_bib26","doi-asserted-by":"crossref","first-page":"17122","DOI":"10.1074\/jbc.M000300200","article-title":"The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies","volume":"275","author":"Brahms","year":"2000","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.autrev.2008.12.001_bib27","doi-asserted-by":"crossref","first-page":"R704","DOI":"10.1186\/ar1729","article-title":"Clinical evaluation of autoantibodies to a novel PM\/Scl peptide antigen","volume":"7","author":"Mahler","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2008.12.001_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1128\/CDLI.12.1.107-113.2005","article-title":"Improved serological differentiation between systemic lupus erythematosus and mixed connective tissue disease by use of an SmD3 peptide-based immunoassay","volume":"12","author":"Mahler","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2008.12.001_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1521-6616(03)00037-8","article-title":"Advances in B-cell epitope analysis of autoantigens in connective tissue diseases","volume":"107","author":"Mahler","year":"2003","journal-title":"Clin Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2008.12.001_bib30","first-page":"2374","article-title":"A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories","volume":"30","author":"Fritzler","year":"2003","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2008.12.001_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s001090050381","article-title":"Identification of an alpha-helical epitope region on the PM\/Scl-100 autoantigen with structural homology to a region on the heterochromatin p25beta autoantigen using immobilized overlapping synthetic peptides","volume":"78","author":"Bluthner","year":"2000","journal-title":"J Mol Med"},{"issue":"6","key":"10.1016\/j.autrev.2008.12.001_bib32","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1186\/ar2548","article-title":"Limited reliability of the indirect immunofluorescence technique for the detection of anti-Rib-P antibodies","volume":"10","author":"Mahler","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2008.12.001_bib33","series-title":"6th international congress on Autoimmunity","article-title":"Anti-PM1-Alpha antibodies: analytical evaluation in two centers","author":"Mahler","year":"2008"},{"key":"10.1016\/j.autrev.2008.12.001_bib34","series-title":"5th international congress on Autoimmunity","article-title":"Sero-clinical aspects of autoantibodies to a PM\/Scl peptide with special emphasis on a cohort of 495 systemic sclerosis patients","author":"Mahler","year":"2006"},{"issue":"3","key":"10.1016\/j.autrev.2008.12.001_bib35","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1046\/j.1365-2249.2002.01991.x","article-title":"Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associations","volume":"130","author":"Van Eenennaam","year":"2002","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2008.12.001_bib36","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/clinchem\/48.12.2171","article-title":"Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests","volume":"48","author":"Hoffman","year":"2002","journal-title":"Clin Chem"},{"issue":"12","key":"10.1016\/j.autrev.2008.12.001_bib37","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1373\/clinchem.2004.035964","article-title":"Detection of anti-SSA antibodies by indirect immunofluorescence","volume":"50","author":"Bossuyt","year":"2004","journal-title":"Clin Chem"},{"issue":"9\u201310","key":"10.1016\/j.autrev.2008.12.001_bib38","first-page":"517","article-title":"Detection and identification of significant ANAs in previously determined ANA negative samples","volume":"51","author":"Kidd","year":"2005","journal-title":"Clin Lab"},{"key":"10.1016\/j.autrev.2008.12.001_bib39","series-title":"10th international workshop on Autoantibodies and Autoimmunity","article-title":"Distribution of autoantibodies against PM\/Scl75 and PM\/Scl100 in patients with systemic sclerosis","author":"Hanke","year":"2008"},{"issue":"7","key":"10.1016\/j.autrev.2008.12.001_bib40","first-page":"1528","article-title":"Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA","volume":"34","author":"Santiago","year":"2007","journal-title":"J Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997208002425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997208002425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T04:09:07Z","timestamp":1589429347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997208002425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1568997208002425"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2008.12.001","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}